top of page
1999-063_SOULAGES_num4000_nr-1536x1382.jpg

Marc is a rising star in the area. He's a very thoughtful and capable advocate who understands what works best before the judges and the courts.

Chambers and Partners 2025

459A0292rr_edited.jpg

Marc Lauzeral

Partner

Lawyer registered at the Paris bar

UPC Representative

ml@schertenleib-avocats.com

  • LinkedIn - Black Circle

Marc Lauzeral is a lawyer at the Paris Bar and a Unified Patent Court Representative.

 

Marc’s practice is focused on complex cross-border patent, SPC and trade secrets disputes.

 

Marc has extensive experience at every stage of litigation, from preliminary injunction to final hearing, in first instance and in appeal before French courts and the Unified Patent Court where he advised clients before the French, German and Italian Divisions. 

Before joining Schertenleib, Marc worked as a lawyer in a European IP boutique and in the IP/IT department of an international law firm. 

Marc was also Law Clerk for the intellectual property judges (3rd civil chamber) of Lyon Court of First Instance. This experience allowed him to prepare more than 50 IP cases for the judges, to attend hearings and deliberations, and to draft decisions.  ​​

Marc is fluent in French and in English.

Education

Master II Intellectual Property Law, Jean Moulin Lyon III University

Master I Business Law, Jean Moulin Lyon III University

License degree in Private Law, Jean Moulin Lyon III University

LL.M., Global Business Law, Columbia Law School (ongoing) 

 

Affiliation 

AIPPI - Member of the UPC Standing Committee, LES, APEB 

What others say

Next Generation Partner, Legal 500

Individuals: Litigation - Bronze - IAM Patent

Best lawyers : Ones to Watch

 Rising Star, IP Star, Managing IP

Publications 

Saisie in front of the UPC: a practical guide, Journal of Intellectual Property Law and Practice, Oxford University Press, DOI 10.1093/jiplp/jpae077

Contributor for France, France, Enforcement of Unified Patent Jurisdiction Decisions, Wolters Kluwer

National rapporteur in 2018 and 2019 for question B, relating to intellectual property issues, of the LIDC Congress published by Éditions Springer

Significant public cases

  • Represented a generic company in its intervention proceedings before the Milan Central Division of the Unified Patent Court

  • Represented an subsea test operator before the Paris Local Division of the Unified Patent Jurisdiction in seizure, validity and infringement proceedings (first seizure decision handed down by the Paris Local Division)

  • Represented a medical device manufacturer in a patent invalidity dispute relating to an ultrasound renal denervation device 

  • Represented a generic company in patent infringement litigation relating to an S1P1 inhibitor used in the treatment of relapsing-remitting multiple sclerosis 

  • Represented three generic companies in three infringement proceedings relating to an aryl urea compound used in the treatment of liver and kidney cancer

  • Represented a generic laboratory in patent litigation relating to  an insulin glargine injection device

  • Represented a major player in aesthetic medicine in a dispute over know-how (claim for more than 150 million euros) and two patents relating to a process for manufacturing hyaluronic acid fillers

  • Represented a major retailer in a patent infringement dispute relating to laminates incorporated in diapers 

  • Represented a manufacturer of hydroalcoholic and professional cleaning solutions in proceedings to revoke a 145 CPC order relating to alleged misappropriation of know-how

  • Represented a major global telephone manufacturer in patent infringement litigation relating to a presentation of information*

  • Represented an originator in a patent infringement action relating to a monoclonal antibody used in the treatment of diabetes*.

  • Represented an originator in a patent infringement action relating to a monoclonal antibody used in the treatment of psoriasis*.

  • Represented a major global toy manufacturer in patent infringement litigation for a sealing device*.

  • Represented an originator in a patent infringement action relating to a statin*.

 

* prior to Schertenleib Avocats

© 2024 SCHERTENLEIB AVOCATS

MANDATORY INFORMATION

bottom of page